February 13, 2008 Printable Version Newsletter Archive
LEGISLATIVE
  • President’s Day Recess Presents Critical Opportunity to Contact Congress
  • ACC Supporting “Family Smoking Prevention and Tobacco Control Act”
  • House Resolution Designed to Raise Awareness of National Congenital Heart Defects
  • REGULATORY
  • FDA Approves New Drug-Eluting Stent for Opening Clogged Heart Arteries
  • QUALITY
  • Health System Reform Takes Center Stage at ACC Summit
  • New ACC Web Site Focuses on Health IT
  • ISO Quality Ambassadors
  • LEGISLATIVE

    President’s Day Recess Presents Critical Opportunity to Contact Congress
    While we were successful in preventing the 10 percent cut to Medicare physician payment from taking place on Jan. 1, congressional intervention only delayed the cuts for six months. The upcoming President's Day Congressional Recess (Feb. 15-25) is a critical opportunity to reach out to members of the Senate and impress on them the importance of meeting their self-imposed deadline of July 1 for preventing cuts to Medicare that will endanger the access to care of millions of beneficiaries. The ACC urges all members to contact their Senators and urge them to:

    • stop the payment cuts for 18 months;
    • provide a positive update through 2009 that covers the increase in the cost of care;
    • pave the way for a permanent replacement of the physician update formula; and
    • oppose cuts to medical imaging services and support policies that foster imaging appropriateness and quality.

    Go to www.acc.org/can to take action or call the ACC’s toll free grassroots hotline at 800-210-7193.

    ACC Supporting “Family Smoking Prevention and Tobacco Control Act”
    The ACC encourages members to contact their lawmakers in support of H.R. 1108/S. 625, the "Family Smoking Prevention and Tobacco Control Act." This legislation, which the ACC has long supported through its work with the Partners for Effective Tobacco Policy (PARTNERS), would give the FDA the authority to regulate the manufacture, distribution, sale, labeling, advertising and promotion of tobacco products to protect the public health. The legislation has moved further in this Congress than in the past and the goal is to achieve enactment this year. The bill currently has 55 Senate cosponsors and was approved by the Senate Health, Education, Labor and Pensions (HELP) Committee last summer. It h as 218 cosponsors in the House and is expected to be marked up by the House Energy and Commerce Committee this spring. It is sponsored by Senators Edward Kennedy (D-MA) and John Cornyn (R-TX), and Representatives Henry Waxman (D-CA) and Tom Davis (R-VA).

    House Resolution Designed to Raise Awareness of National Congenital Heart Defects
    The ACC last week sent a letter to Rep. Robert Andrews (D-NJ) thanking him for introducing H.Res. 858, which does the following:

    • supports the goals and ideals of the National Congenital Heart Defect Awareness Week sponsored by the Congenital Heart Information Network;
    • supports efforts to reinvigorate research on congenital heart defects and diseases (`CHDs') through increasing funding for such research;
    • supports the education of parents and the medical community on CHDs symptoms and on the importance of newborn screenings for such symptoms;
    • encourages awareness of the often life-long medical, financial, and emotional toll faced by CHDs victims, survivors, and their loved ones; and
    • requests that President Bush issue a proclamation for all Americans to acknowledge, celebrate and honor CHDs survivors, families, medical professionals, and researchers.

    ACC members are encouraged to contact their House member and ask them to be a cosponsor of the resolution. For more information on National Congenital Heart Defect Awareness Week, go to: http://tchin.org/aware/facts.htm.

    REGULATORY

    FDA Approves New Drug-Eluting Stent
    The FDA has approved the Endeavor Zotarolimus-Eluting Coronary Stent. The Endeavor is the first drug-eluting stent approved since 2004 and the first since FDA convened its Circulatory System Devices Panel in 2006 to discuss evidence of the rare risk of blood clots occurring in patients who receive drug-eluting stents. The stent is manufactured by Medtronic, Inc., of Minneapolis. For more information, go to: http://www.fda.gov/bbs/topics/NEWS/2008/NEW01787.html.

    QUALITY

    Health System Reform Takes Center Stage at ACC Summit
    The ACC held a highly successful Health System Reform Summit Feb. 1 - 2 in Washington, D.C. The Summit brought together leaders in the health care field, ACC members, industry, payers and other health care organizations to discuss critical issues facing health system reform, including financing, patient needs, models for success and much more. In addition, the ACC's Blue Ribbon Panel released a draft summary of findings that will be fleshed out over the course of the next few months to better define ACC's role in reforming the health system. A reactor panel and breakout sessions encouraged thoughtful discussion and feedback on what is needed to ensure physicians have a seat at the table. Click here for the final agenda. To learn more about the ACC’s health system reform efforts and join discussions focused on these issues visit: www.lewinreport.acc.org.

    New ACC Web Site Focuses on Health IT
    The ACC recently launched its new Web site focused on health care technology. The site aims to:

    • Support ACC’s health information technology (HIT) efforts to promote quality in cardiovascular health.
    • Provide education and useful resources to help promote HIT adoption
    • Serve as a trusted source for information on healthcare technology for ACC members.
    • Provide tools and programs to assist members in implementing HIT, including e-Prescribing and EHR Toolkit sections.

    The Healthcare Technology site also provides helpful information on HIT organizations, terminology and acronyms. Bookmark the site (www.acc.org/healthit). You can also learn more at ACC.08 in Chicago by visiting the ACC Central booth on the Expo floor.

    ISO Quality Ambassadors
    As the ACC ramps up its multi-year “Quality First” outreach campaign around Health System Reform, we are looking for volunteers to serve as “Quality First Ambassadors” and speak at local Chapter meetings and/or other ACC or quality-related events. We’re basically talking about putting our ACC-AHA Guidelines and Performance Measures into practice. We’re also launching two pilot projects (paired with the NCDR) aimed at improving patient medication compliance. Leading in promoting quality gets us a “seat at the table” for health system reform, but we can’t do it without your help. If you are interested in participating in this very worthy endeavor, contact sfairban@acc.org.

     

    ADVERTISEMENT








    Back to Top | | Copyright © 2008 American College of Cardiology
    ACCInTouch Facebook Twitter LinkedIn
    Heart House | 2400 N Street, NW | Washington, DC 20037